Cargando…
Growth-factor reduced Matrigel source influences stem cell derived brain microvascular endothelial cell barrier properties
BACKGROUND: Patient-derived induced pluripotent stem cells (iPSCs) are an innovative source as an in vitro model for neurological diseases. Recent studies have demonstrated the differentiation of brain microvascular endothelial cells (BMECs) from various stem cell sources, including iPSC lines. Howe...
Autores principales: | Patel, Ronak, Alahmad, Abraham J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828815/ https://www.ncbi.nlm.nih.gov/pubmed/27068644 http://dx.doi.org/10.1186/s12987-016-0030-5 |
Ejemplares similares
-
EPAC2 acts as a negative regulator in Matrigel-driven tubulogenesis of human microvascular endothelial cells
por: Ikeda, Takayuki, et al.
Publicado: (2021) -
From MEFs to Matrigel 3: Passaging hESCs from Matrigel onto Matrigel
por: Zhang, Jin, et al.
Publicado: (2008) -
SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties
por: Alkabie, Samir, et al.
Publicado: (2016) -
Functional enhancement of acute infracted heart by coinjection of autologous adipose-derived stem cells with matrigel
por: WANG, Bao-Zhu, et al.
Publicado: (2023) -
Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansion
por: Nguyen, Eric H., et al.
Publicado: (2017)